JPS6047552B2 - C-reactive protein measurement reagent - Google Patents

C-reactive protein measurement reagent

Info

Publication number
JPS6047552B2
JPS6047552B2 JP3957776A JP3957776A JPS6047552B2 JP S6047552 B2 JPS6047552 B2 JP S6047552B2 JP 3957776 A JP3957776 A JP 3957776A JP 3957776 A JP3957776 A JP 3957776A JP S6047552 B2 JPS6047552 B2 JP S6047552B2
Authority
JP
Japan
Prior art keywords
crp
reagent
solution
lecithin
cholesterol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP3957776A
Other languages
Japanese (ja)
Other versions
JPS52123295A (en
Inventor
友生 岡田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eiken Chemical Co Ltd
Original Assignee
Eiken Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eiken Chemical Co Ltd filed Critical Eiken Chemical Co Ltd
Priority to JP3957776A priority Critical patent/JPS6047552B2/en
Publication of JPS52123295A publication Critical patent/JPS52123295A/en
Publication of JPS6047552B2 publication Critical patent/JPS6047552B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Description

【発明の詳細な説明】 本発明は、C反応性蛋白質(以下CRPという。[Detailed description of the invention] The present invention relates to C-reactive protein (hereinafter referred to as CRP).

)測定用試薬に関するものである。従来CRPは肺炎球
菌のC分画と呼ばれる多糖に対し親和性を有する蛋白質
をいい、他の種々の多糖体例えば硫酸デキストラン、ヘ
パリン等とあるいは該酸とも弱い親和性を示すことが知
られている。
) Regarding measurement reagents. Conventionally, CRP refers to a protein that has an affinity for a polysaccharide called the C fraction of pneumococci, and is known to have a weak affinity with various other polysaccharides such as dextran sulfate, heparin, etc., or with the same acid. .

このCRP(7)C多糖体との親和性を利用したCRP
測定法が提案されたことがあるが、この方法に使用する
試薬が不安定であり測定結果が一定しない等の理由で今
日では使用されていない。近年CRPとC多糖体との親
和性について研究が進み、フオスフオリルコリン残基が
CRPとの親和性に重要な意義があり、この反応にはカ
ルシウムイオンが必須のものであることも知られるよう
になつた。CRPは種特異的な抗原性が強いことから、
従来は抗CRP抗体を利用した免疫化学的測定法が実用
化されている。しかし、この方法の最も一般的な毛細管
内沈降反応によるものは、操作が繁雑であり、成績の判
定に長時間を要し、かつ、特異的な抗CRP抗体の製造
に長期間を要する等の難点があつた。本発明は、上記難
点を改善するものであつて、比較的容易に得られるレシ
チンを原料として製造上の困難を克服するとともに測定
手技が極めて簡単であり、かつ、m分以内の短時間て判
定できるスライド凝集反応用試薬を提供するものである
CRP utilizing this affinity with CRP(7)C polysaccharide
Although a measurement method has been proposed, it is not used today because the reagents used in this method are unstable and the measurement results are inconsistent. In recent years, research has progressed on the affinity between CRP and C-polysaccharide, and it is also known that phosphorylcholine residues have an important significance in the affinity with CRP, and that calcium ions are essential for this reaction. It became like that. Since CRP has strong species-specific antigenicity,
Conventionally, immunochemical measurement methods using anti-CRP antibodies have been put into practical use. However, the most common method of this method, which uses capillary precipitation reaction, is complicated, requires a long time to judge the results, and requires a long time to produce a specific anti-CRP antibody. There was a problem. The present invention aims to improve the above-mentioned difficulties, overcomes the manufacturing difficulties by using lecithin, which is relatively easily obtained, as a raw material, and has extremely simple measurement techniques, and can be determined in a short time of less than m minutes. The present invention provides reagents for slide agglutination reactions that can be used for slide agglutination reactions.

本発明のCRP測定用試薬は、このフオスフオリルコリ
ン残基を有するコリンフオスフアタイド例えばレシチン
、スフィンゴミエリン等もカルシウムイオンの存在下で
CRPと強い親和性を示すとの報告にもとすいて、開発
されたものである。本発明のCRP測定用試薬は、レシ
チン、コレステロールおよび脂溶性染料を界面活性剤と
ともに5〜40%の塩化コリンを含有する緩衝液に均一
に懸濁した第1液と、0.02〜0.2Mのカルシウム
およびマグネシウムイオンを含有す、る生理食塩水門の
第2液とからなることを特徴とするものである。また、
前記第1液と、0.02〜0.2rV1のカルシウムお
よびマグネシウムイオンを含有する生理食塩水に0.2
〜1.0%のソジウムポリアネトールスルフオネートを
加えた第2液とからなることを特徴とするものである。
The reagent for measuring CRP of the present invention is based on the report that choline phosphoratiides having this phosphorylcholine residue, such as lecithin and sphingomyelin, also show a strong affinity for CRP in the presence of calcium ions. , was developed. The reagent for measuring CRP of the present invention includes a first solution in which lecithin, cholesterol, and a fat-soluble dye are uniformly suspended in a buffer containing 5 to 40% choline chloride together with a surfactant; It is characterized in that it consists of a second physiological saline sluice containing 2M calcium and magnesium ions. Also,
0.2 to the first solution and physiological saline containing 0.02 to 0.2 rV1 of calcium and magnesium ions.
It is characterized by consisting of a second liquid to which ~1.0% of sodium polyanethole sulfonate is added.

すなわち、本発明は、レシチン、コレステロールの懸濁
液に塩化コリンを加え、かつ、レシチンの不安定化要因
と思われるカルシウム、マグネシウム両イオンを別の溶
液に含有させることによつて、試薬を安定化したもので
ある。
That is, the present invention stabilizes the reagent by adding choline chloride to a suspension of lecithin and cholesterol, and adding calcium and magnesium ions, which are thought to be factors that destabilize lecithin, to a separate solution. It has become.

通常、レシチン、コレステロールの懸濁液とCRPとの
反応は、当該粒子の凝集という形で現れ、顕微鏡で観察
するかあるいは比濁法等の光学的観察によるのが一般的
であるが、本発明の試薬を使用すればコレステロールを
脂溶性染料で染色するから、スライド上で凝集反応に類
似した状態となるので、容易に肉眼観察することができ
る。
Normally, the reaction between a suspension of lecithin or cholesterol and CRP appears in the form of aggregation of the particles, and is generally observed with a microscope or by optical observation such as turbidimetry. If this reagent is used, cholesterol is stained with a fat-soluble dye, which creates a state similar to an agglutination reaction on the slide, making it easy to observe with the naked eye.

なお、上記の操作では測定値がバラつき、免疫化学的測
定法の測定値とも必ずしも一致しないこともあるので、
その原因について研究を集めた結果本発明者か血清中の
補体活性にあることを見出した。このため、被検血清を
56゜Cて3吟間加熱して非働化するか、あるいは試薬
第2液0.2〜2.0%のソジウムポリアネトールスル
フオネートを加えてその補体活性を押えることにより、
本発明によるCRP測定値は免疫化学的測定法の測定値
と一致するようになつた。本発明のCRP測定用試薬の
調製は、例えば次の通りである。
Please note that the above procedure may cause the measured values to vary and may not necessarily match the measured values for immunochemical assays.
As a result of research into the cause, the present inventor discovered that it lies in complement activity in serum. For this purpose, either inactivate the test serum by heating it at 56°C for 3 minutes, or add 0.2 to 2.0% sodium polyanethole sulfonate to the second reagent solution to increase its complement activity. By pressing
CRP measurements according to the present invention now match those of immunochemical assays. The preparation of the CRP measurement reagent of the present invention is, for example, as follows.

O第1液の調製 コレステロール0.8〜1.2%、レシチン0.2〜0
.6%、スパン60(商品名(ゾルビタン モノステア
レート)0.05%、スタン ブラック0.1〜0.2
%を含むアルコール溶液の1容を、5 〜40%塩化コ
リンを含むベロナール緩衝液(PH8.6)の9容に対
して徐々に混合し、均一に懸濁する。
Preparation of O first solution Cholesterol 0.8-1.2%, Lecithin 0.2-0
.. 6%, Span 60 (Product name (Zorbitan Monostearate) 0.05%, Stan Black 0.1-0.2
Gradually mix 1 volume of alcoholic solution containing 1% to 9 volumes of veronal buffer (pH 8.6) containing 5-40% choline chloride to homogeneously suspend.

保存にあたつては、アジ化ナトリウム等の防腐剤を適宜
添加゛する。O第2液の調製 生理食塩水に0.02〜0.2Mの塩化カルシウムおよ
び塩化マグネシウムを溶解あるいは更に0.2〜1.0
%のソジウムポリアネトールスルフオネートを添加する
During storage, add preservatives such as sodium azide as appropriate. Preparation of second solution Dissolve 0.02-0.2M of calcium chloride and magnesium chloride in physiological saline or further dissolve 0.2-1.0M of calcium chloride and magnesium chloride.
% sodium polyanethole sulfonate.

次に、本発明の試薬によるCRP測定の手技は、例えば
次の通りである。
Next, the procedure for CRP measurement using the reagent of the present invention is, for example, as follows.

0CRP測定の手技 被検血清もしくは体液0.05m1をスライド板上に採
り、これに0.05m1の第2液を加えて混和した後第
1液1滴を加えて8分間反応させ、凝集の有無を判定す
る。
Procedure for measuring 0CRP Take 0.05ml of the serum or body fluid to be tested on a slide plate, add 0.05ml of the second liquid to it, mix it, then add one drop of the first liquid and let it react for 8 minutes to check for agglutination. Determine.

以下実施例を掲げて、本発明のCRP測定用試薬を具体
的に説明する。
The CRP measuring reagent of the present invention will be specifically explained below with reference to Examples.

実施例1 コレステロール0.9%、レシチン0.3%、スパン6
0(商品名)0.5%、スタン ブラック0.1%を含
むアルコール溶液の1溶を、10%塩化コリンを含むベ
ロナール緩衝液(PH8.6)の9容に徐々に混合して
調製した第1液と、0.02M塩化カルシウムおよび塩
化マグネシウムを含有する生理食塩水の第2液を組合せ
、上記CRP測定の手技に従い56゜Cで30分間加熱
した血清15例についてCRPを測定した。
Example 1 Cholesterol 0.9%, lecithin 0.3%, Span 6
0 (trade name) 0.5% and Stan black 0.1% were gradually mixed into 9 volumes of veronal buffer (pH 8.6) containing 10% choline chloride. The first solution was combined with a second solution of physiological saline containing 0.02 M calcium chloride and magnesium chloride, and CRP was measured for 15 serum samples heated at 56° C. for 30 minutes according to the CRP measurement procedure described above.

凝集の状態を、次の基準により測定した。C2ll定基
準 鼎・・・・・・大きな凝集塊が認められる+・・・・・
・中程度の凝集塊が認められる廿−・・・・小さな凝集
塊が多数認められる+・・・・・・きわめて小さな凝集
塊が無数に認められる土・・・・・・凝集塊が不明瞭で
ある一・・・・・・凝集塊が全く認められない結果を第
1表に示す。
The state of aggregation was measured according to the following criteria. C2ll standard test...Large aggregates are observed+...
・Soil where medium-sized aggregates are observed - Many small aggregates are observed + Soil where numerous extremely small aggregates are observed: Agglomerates are unclear Table 1 shows the results in which no agglomerates were observed.

第1表に示すように、非働化した被検血清を用い本発明
の試薬によつて測定したところ、従来の免疫学的測定法
てある沈降法と良く一致することが判つた。
As shown in Table 1, when inactivated test serum was measured using the reagent of the present invention, it was found that the results were in good agreement with the precipitation method, which is a conventional immunoassay method.

実施例2 コレステロール0.9%、レシチン0.45%、スパン
80(商品名)0.5%、スタン ブラック0.15%
を含むアルコール溶液の1容を、10%塩化コリンを含
むベロナール緩衝液(PH8.6)の9容に徐々に混合
して調製した第1液と、0.03Mの塩化カルシウム、
0.02Mの塩化マグネシウムおよび0.2%のソジウ
ムポリアネトールスルフオネートを加えた第2液を組合
せ、上記CRP測定の手技に従い新鮮な血清1C@およ
び髄液5例についてCRPを測定した。
Example 2 Cholesterol 0.9%, Lecithin 0.45%, Span 80 (trade name) 0.5%, Stan Black 0.15%
A first solution prepared by gradually mixing 1 volume of an alcoholic solution containing 10% choline chloride with 9 volumes of veronal buffer (pH 8.6) containing 10% choline chloride, and 0.03M calcium chloride,
A second solution containing 0.02 M magnesium chloride and 0.2% sodium polyanethole sulfonate was combined, and CRP was measured for fresh serum 1C@ and 5 cases of cerebrospinal fluid according to the procedure for CRP measurement described above.

判定基準は実施例1に同じ。結果を第2表に示す 第2表に示すように、補体活性の強い検体(新鮮な血清
、髄液等)においても、ソジウムポリアネトールスルフ
オネートを添加した本発明の試薬によるCRPの測定値
は非働化操作を省略しても従来の沈降法とよく一致する
ことが判つた。
The judgment criteria are the same as in Example 1. The results are shown in Table 2. As shown in Table 2, even in specimens with strong complement activity (fresh serum, cerebrospinal fluid, etc.), the reagent of the present invention containing sodium polyanethole sulfonate is effective for CRP. It was found that the measured values were in good agreement with the conventional sedimentation method even if the inactivation operation was omitted.

実施例3コレステロール1.2%、レシチン0.6%、
スパン60(商品名)0.5%、オイル レッド0.5
%を含むアルコール溶液の1容を、15%塩化コリンを
含むベロナール緩衝液(PH8.6)の9容に徐々に混
合して調製した第1液と、0.05r1−4塩化カルシ
ウム、0.02M塩化マグネシウムおよび0.3%ソジ
ウムポリアネトールスルフオネートを含有する第2液を
組合せ、上記CRP測定の手技に従い血清5種について
CRPを定量的に測定した。
Example 3 Cholesterol 1.2%, lecithin 0.6%,
Span 60 (product name) 0.5%, Oil Red 0.5
The first solution was prepared by gradually mixing 1 volume of an alcoholic solution containing 15% choline chloride with 9 volumes of veronal buffer (pH 8.6) containing 15% choline chloride, 0.05r1-4 calcium chloride, 0. A second solution containing 0.2 M magnesium chloride and 0.3% sodium polyanethole sulfonate was combined, and CRP was quantitatively measured for five types of serum according to the CRP measurement procedure described above.

なお、被検血清は、下記第3表の稀釈倍率により生理食
塩水で稀釈した。結果を第3表に示す。
The test serum was diluted with physiological saline according to the dilution ratio shown in Table 3 below. The results are shown in Table 3.

第3表に示すように、本発明の試薬による凝集の最終稀
釈濃度と毛細管内沈降法の沈降を示す最終稀釈濃度と良
く一致することが判つた。
As shown in Table 3, it was found that the final dilution concentration for agglutination using the reagent of the present invention was in good agreement with the final dilution concentration for sedimentation using the capillary sedimentation method.

以上の如く、本発明のCRP測定用試薬は、二液として
試薬を安定化して測定値のバラツキを少くし、免疫化学
的測定法による測定値とよく合致させることができる。
As described above, the reagent for CRP measurement of the present invention stabilizes the reagent as a two-part reagent, reduces the variation in measured values, and can match well with the measured values by immunochemical measurement.

Claims (1)

【特許請求の範囲】 1 レシチン、コレステロールおよび脂溶性染料を界面
活性剤とともに5〜40%の塩化コリンを含有する緩衝
液に均一に懸濁した第1液と、0.02〜0.2Mのカ
ルシウムおよびマグネシウムイオンを含有する生理食塩
水の第2液とからなることを特徴とするC反応性蛋白質
測定用試薬。 2 レシチン、コレステロールおよび脂溶性染料を界面
活性剤とともに5〜40%の塩化コリンを含有する緩衝
液に均一懸濁した第1液と、0.02〜0.20Mのカ
ルシウムおよびマグネシウムイオンを含有する生理食塩
水に0.2〜1.0%のソジウムポリアネトールスルフ
オネートを加えた第2液とからなることを特徴とするC
反応性蛋白質測定用試薬。
[Claims] 1. A first solution in which lecithin, cholesterol and a fat-soluble dye are uniformly suspended together with a surfactant in a buffer containing 5 to 40% choline chloride; A reagent for measuring C-reactive protein, comprising a second solution of physiological saline containing calcium and magnesium ions. 2. A first solution containing lecithin, cholesterol and a fat-soluble dye, together with a surfactant, uniformly suspended in a buffer containing 5-40% choline chloride, and 0.02-0.20M calcium and magnesium ions. C, characterized in that it consists of a second liquid in which 0.2 to 1.0% sodium polyanethole sulfonate is added to physiological saline.
Reagent for measuring reactive proteins.
JP3957776A 1976-04-08 1976-04-08 C-reactive protein measurement reagent Expired JPS6047552B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3957776A JPS6047552B2 (en) 1976-04-08 1976-04-08 C-reactive protein measurement reagent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3957776A JPS6047552B2 (en) 1976-04-08 1976-04-08 C-reactive protein measurement reagent

Publications (2)

Publication Number Publication Date
JPS52123295A JPS52123295A (en) 1977-10-17
JPS6047552B2 true JPS6047552B2 (en) 1985-10-22

Family

ID=12556921

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3957776A Expired JPS6047552B2 (en) 1976-04-08 1976-04-08 C-reactive protein measurement reagent

Country Status (1)

Country Link
JP (1) JPS6047552B2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62259063A (en) * 1986-05-02 1987-11-11 Oriental Yeast Co Ltd Quantitative determination of c-reactive protein
JP2654932B2 (en) * 1995-06-16 1997-09-17 オリエンタル酵母工業株式会社 C-reactive protein measurement reagent
ATE438097T1 (en) * 2000-08-29 2009-08-15 Kyowa Medex Co Ltd HIGHLY REPRODUCABLE AGGLUTINATION IMMUNOASSAY METHOD AND REAGENTS
CN1522368A (en) * 2002-04-05 2004-08-18 ���µ�����ҵ��ʽ���� Test strip for chromatography and process for producing the same

Also Published As

Publication number Publication date
JPS52123295A (en) 1977-10-17

Similar Documents

Publication Publication Date Title
US4419453A (en) Immunological agglutination assays with dyed or colored latex and kits
KR880001533B1 (en) Measuring method for reaction of the entigen and the antibody
EP0050660B1 (en) Antibody detection process and reagents therefor
CA1146852A (en) Reagent for latex agglutination
CN107894509B (en) A method of improving latex immunoturbidimetry antigen excess and the range of linearity
CN111057150B (en) Latex microsphere, application thereof and glycosylated hemoglobin detection kit
Maclagan The preparation and use of colloidal gold sols as diagnostic agents
US4429040A (en) Method and reagent for the detection of fibrin monomer
JPS6047552B2 (en) C-reactive protein measurement reagent
SU1431662A3 (en) Method of producing reagent for effecting agglutination reaction
JP2005283250A (en) Measuring method of gold colloid agglutination reaction
DE60026023T2 (en) PROCESS FOR THE IMMUNOLOGICAL DETERMINATION OF PIVKA-II
CN114594269B (en) Serum amyloid A detection kit and preparation method thereof
CN112730848B (en) Kit and method for detecting retinol binding protein
JP3220546B2 (en) Method for measuring antigen or antibody in the presence of immune complex
US5637452A (en) Kit for an initial screen for abnormal platelet condition comprising propyl gallate or tannin and a metal ion
JPH1123573A (en) Immunological measuring method
JPH0658935A (en) Immunoassay and reagent therefor
US3955923A (en) Serologic reaction method
JP7483168B2 (en) Ferritin measurement reagent
CN112051401B (en) Pepsinogen's assay kit
JP3290520B2 (en) Antiphospholipid antibody assay
JPH0251150B2 (en)
JPS62247259A (en) Reagent for latex coagulation
JP3544787B2 (en) Latex turbidimetric immunoassay